AUCTORES
Globalize your Research
Research Article
*Corresponding Author: Kalyani Raju, Consultant Pathologist, New Kamadhenu Hospital, Kolar. 563102. Karnataka. India.
Citation: Priyanka P. Kamarthi, Kamarthi P., Raju K., (2023), Profile of Haematological Parameters in Covid-19 Positive Cases -A Cross Sectional Study, Journal of Clinical and Laboratory Research. 6(2); DOI:10.31579/2768-0487/110
Copyright: © 2023, Kalyani Raju. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 11 July 2023 | Accepted: 24 August 2023 | Published: 31 August 2023
Keywords: blood group in COVID; COVID–19; ESR in COVID; haematological parameters; SARS–CoV–2
Introduction
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), a fast spreading and disastrous global pandemic. We have studied changes in haematology parameters in COVID-19 infected patients.
Objective / Aim: To assess haematological Parameters in COVID positive cases and analyse difference in profile of haematological parameters between categories of COVID positive cases.
Methods
This is a laboratory observation retrospective study. All COVID RT-PCR (Real Time Polymerase Chain Reaction) Positive cases from June 2020 to May 2022 was considered for the study. The haematology parameters of cases including blood group and ESR were captured from hospital records and analysed for the difference between mild (Category A), moderate (Category B) and severe cases (Category C). Statistical analysis was done using SPSS software version 22. p value less than 0.05 was considered statistically significant.
Results
Total WBC count, absolute neutrophil count (ANC), absolute lymphocyte count (ALC), absolute eosinophil count (AEC), absolute monocyte count (AMC), platelet count, neutrophil lymphocyte ratio (NLR), monocyte lymphocyte ratio (MLR), eosinophil lymphocyte ratio (ELR) and platelet lymphocyte ratio (PLR) between the three categories of cases were statistically significant. The commonest blood group was O positive and majority of O positive cases were in Category C. 81.9% cases tested for ESR showed raised ESR.
Conclusion
Haematology parameters can be considered to predict progression of the disease and assess prognosis in COVID-19 infection. Total WBC count, ANC, ALC, AEC, AMC, platelet count, NLR, MLR, ELR and PLR can be considered while monitoring COVID-19 cases.
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), a fast spreading and disastrous global pandemic [1]. In December 2019, an outburst of COVID-19 occurred, caused by SARS-CoV-2 in Wuhan, China and briskly infected people across the globe. The novel virus was named as SARS-CoV-2 2019 by World Health Organization (WHO) due to 79% resemblance with SARS-CoV [2]. Corona virus disease 2019 (COVID-19) clinical features ranges from flu-like symptoms to multiple organ failure and death [3].
Various studies have indicated that the haematological parameters are markers of disease severity and advocated that the parameters arbitrate the progression of the disease.[4] There are less published information about the changes in haematology parameters in COVID-19 infected patients.[5]
Ministry of Health and family welfare guidelines has classified COVID-19 as Mild (Category A), Moderate (Category B) and Severe (Category C) categories. Category C COVID is defined as the patients having fever ≥38°C (100.4°F), respiratory rate (RR) >30 breaths/min; severe respiratory distress; or pulse oximeter oxygen saturation ≤90% in room air and neutrophil lymphocyte ratio (NLR) of >5. Category A patients are asymptomatic/patients with mild symptoms with RR <24>94% in room air and NLR 1-3. Category B patients are symptomatic patient with mild to moderate pneumonia with no signs of severe disease, RR 24-30/m or SPO2 90%-94% at room air and NLR 4-5.[6] Few studies have comprehensively analyzed haematological parameters among patients with Category A, B and C COVID-19 infection.[7] Various studies stated that decreased platelet count is associated with severe COVID-19 and a higher mortality rate.[8,9,10,11,12] So finding efficacious haematological parameters for risk stratification and predicting prognosis is a prime concern.
This is a retrospective analysis to unearth the role of the haematological parameters in COVID-19. Interpreting the changes in haematological parameters in SARS–CoV–2 infected patients may be helpful in understanding the pathophysiology of the disorder and could contribute timely clues to diagnosis and hopefully predicts the prognosis.
This is a laboratory observation retrospective cross section study for duration of six months from June 2020 to May 2022 performed at New Kamadhenu Hospital, a health care center, in Kolar, Karnataka. The objectives of the study were to assess haematological parameters in COVID positive cases and analyse difference in profile of haematological parameters between three categories of COVID positive cases. All the cases positive for COVID test by RT-PCR (Real Time Polymerase Chain Reaction) was considered for the study. The sociodemographic data of the all cases was captured from hospital records.
Data of haematological parameters (complete blood count) along with blood group and erythrocyte sedimentation rate (ESR) was captured from laboratory for each case. Neutrophil lymphocyte ratio (NLR), monocyte lymphocyte ratio (MLR), Eosinophil lymphocyte ratio (ELR) and platelet lymphocyte ratio (PLR) was calculated from the absolute values of each parameter of the case. All the cases were classified into three categories as per the Ministry of Health and family welfare guidelines as Category A, Category B and Category C. Alteration in haematological parameters, blood groups and ESR between categories was noted.
The Data was entered in Microsoft excel sheet. Statistical analysis was done using SPSS software version 22. Continuous variables were expressed as the mean and standard deviation. Categorical variables were presented as counts and percentages in each category. The unpaired Student’s t-test was used for continuous variables. Chi-square (χ) and Fisher’s exact tests was used for categorical variables. p value less than 0.05 was considered statistically significant.
Total number of cases analysed was 410 of which 284 (69.2%) cases were males and 126 (38.2%) females with male to female ratio of 2.2:1. Majority of cases were in the age group of 51-60 years (23.9%) and 41-50 years (21.7%) (Table 1).
| Age group | No of cases (n%) | Males (n%) | Females (n%) |
| 1 month-10 years | 06 (1.4%) | 5 (83.3%) | 1 (16.66%) |
| 10-20 years | 13 (3.1%) | 2 (15.38%) | 11 (84.6%) |
| 20-30 years | 38 (9.2%) | 22 (57.8%) | 16 (42%) |
| 30-40 years | 59 (14.3%) | 47 (79.6%) | 12 (20.4%) |
| 41-50 years | 89 (21.7%) | 65 (73%) | 24 (27%) |
| 51-60 years | 98 (23.9%) | 68 (69.3%) | 30 (20.3%) |
| 61-70 years | 67 (16.3%) | 49 (73.1%) | 18 (26.8%) |
| 71-80 years | 29 (7.2%) | 20 (68.9%) | 9 (31.1%) |
| 81-90 years | 09 (2.1%) | 5 (55.55%) | 4 (44.44%) |
| 91-100 years | 02 (0.4%) | 01(50%) | 01 (50%) |
| Total | 410 (100%) | 284(69.2%) | 126 (30.8%) |
Table 1: Age and sex distribution among cases in the present study.
The minimum age was two months and maximum age was 95 years among cases. The mean age among males was 45 years and in females 22 years. Majority of cases were in Category A (46.3%) followed by Category B (28.6%) and then Category C (25.1%) (Table 2).
| Category | No of cases | % of cases |
| Category A | 190 | 46.3% |
| Category B | 117 | 28.6% |
| Category C | 103 | 25.1% |
| Total | 410 | 100% |
Table 2: Distribution of cases category wise in the present study.
Mean values of red blood cells (RBC) parameters as RBC count, mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC) and red cell diameter width (RDW) between three categories of cases were not statistically significant by unpaired student’s t-test (Table 3). Only 16 and 4 cases showed MCV ranging from 57-77 fL and 102-104 fL respectively.
| RBC Parameters | Category A n=103 | Category B n=117 | Category C n=190 | p value |
| Count (million/mm3) | 4.70±0.889 | 4.72±0.891 | 4.75±0.91 | 0.881 |
| MCV (fl) | 91.55±5.89 | 91.45±4.25 | 91.35±4.15 | 0.594 |
| MCH (pg) | 30.24±2.63 | 30.32±1.54 | 30.42±1.62 | 0.902 |
| MCHC (g/dl) | 32.26±2.62 | 34.26±2.42 | 33.26±2.52 | 0.901 |
| RDW (%) | 15.03±3.34 | 14.68±2.04 | 14.71 ±2.04 | 0.682 |
Table 3: Distribution of mean values of RBC parameters among three categories of cases.
Anaemia was noted only in 53 cases (12.9%). Median values of haemoglobin, total white blood cells (WBC) count, differential leukocyte count and platelet count was analysed between three categories of cases using chi square test / Fisher’s exact test. In addition, median values of NLR, MLR, ELR and PLR was analysed between three categories of cases using chi square test / Fisher’s exact test. The total WBC count, absolute neutrophil count (ANC), absolute lymphocyte count (ALC), absolute eosinophil count (AEC), absolute monocyte count (AMC), platelet count, NLR, MLR, ELR and PLR between the three categories of cases were statistically significant (Table 4).
| Blood Parameters | Category A n=103 | Category B n=117 | Category C n=190 | p value |
| Haemoglobin (g/dl) | 12.6 (11.2-13.2) | 11.9 (10.9-12.8) | 11.8 (10.8-12.9) | 0.1012 |
| Total WBC Count (Thousand/mm3) | 5.88 (4.40 - 8.27) | 5.02 (3.92- 6.22) | 5.84 (4.34-8.24) | <0> |
| ANC 10⁹ cells per L | 3·49 (2·37–4·39) | 4·39 (2·97–6·33) | 8·28 (5·30–12·12) | <0> |
| ALC 10⁹ cells per L | 1·8 (0·90–1·59) | 0.98 (0·59–1·36) | 0·74 (0·30–0·91) | <0> |
| AEC 10⁹ cells per L | 0.02 (0.01-0.08) | 0.03 (0.01-0.11) | 0.05 (0.03-0.12) | <0> |
| ABC 10⁹ cells per L | 0.01(0.01-0.03) | 0.01(0.01-0.03) | 0.01(0.01-0.03) | 0.38 |
| AMC 10⁹ cells per L | 0.49(0.31-0.63) | 0.48(0.34-0.62) | 0.51(0.32-0.64) | 0.0020 |
| Platelet count | 188.00 (145.50-249.50) | 247.00 (142.5-328.00) | 115.00 (55.75-200.75) | <0> |
| NLR | 2·87 (1·69–4·08) | 4·91 (2·62–7·78) | 17.02 (6·49–24·79) | <0> |
| MLR | 0.52 (0.1-3.6) | 0.56 (0.1-3.8) | 0.58 (0.1-3.8) | 0.0040 |
| ELR | 0.05 (0-0.15) | 0.06 (0-1.2) | 0.08 (0-1.4) | <0> |
| PLR | 89.1(10.81-1304.1) | 158.1(10.81-1304.1) | 288.1(10.81-1304.1) | <0> |
Table 4: Distribution of median values of haemoglobin, WBC and platelet parameters among three categories of cases.
Blood grouping was performed in 74 cases out of 410 cases of which majority were O positive cases (37.8%) followed by B positive (24.3%) and then A positive (20.2%). Majority of cases of O positive (n=18) were in Category C (Table 5). ESR was performed for 157 cases out of 410 of which majority of cases (14%) had ESR between 11-20 mm/hour (Table 6). Out of 157 cases, 127 cases (81.9%) showed raised ESR.
Table 5: Distribution of Blood Group among cases in the present study.
| ESR Range (mm/hour) | No of cases | % of cases |
| 1-10 | 6 | 3.8% |
| 11-20 | 22 | 14% |
| 21-30 | 17 | 10.8% |
| 31-40 | 12 | 7.64% |
| 41-50 | 16 | 10.1% |
| 51-60 | 17 | 10.8% |
| 61-70 | 15 | 9.5% |
| 71-80 | 12 | 7.64% |
| 81-90 | 10 | 6.3% |
| 91-100 | 9 | 5.7% |
| 101-110 | 7 | 4.45% |
| 111-120 | 2 | 1.2% |
| 121-130 | 7 | 4.45% |
| 131-140 | 1 | 0.63% |
| 141-150 | 4 | 2.54% |
Table 6: Distribution of ESR among cases in the present study.
COVID-19 is a viral disease caused by a novel coronavirus SARS-CoV-2. Haematology parameter abnormalities are noted in COVID-19 patients. In this study we have analysed RBC, WBC and platelet parameters between categories A, B and C of COVID RT-PCR positive cases.
In the present study all the RBC indices (Table 5) was normal except in 20 cases (4.8percentage cases) of which 16 cases showed MCV ranging from 57 to 77 fL and 4 cases showed MCV ranging from 102-104 fL. Other cases showed normal RBC indices. This finding was comparable to study done by Lu Chong et al which also showed decrease in MCV values in 9percentage cases.[13]
In present study anaemia was noted in 53 cases (12.9percentage). This finding was comparable to the study done by Helms J et al which also showed 12percentage cases with anaemia.[14] In a study by Tang et al, haemoglobin was decreased in 51percentage of cases with SARS-CoV-2 infection.[7] Decreased haemoglobin was reported to be more marked in Category C.[15] In a study by Zhou et al, no difference was observed in the incidence of anaemia between categories, but the haemoglobin decreased significantly in more severe cases.[8]
In a study by Li Q et al, 4.14percentage (17 cases) of the patients had leukopenia (less than4.0×109 /L) whereas in a study by Liu et al leukopenia was observed in 33percentage cases.[16] In the present study, total WBC count was decreased in Category B and C cases compared with Category A cases.
Liu J et al reported that most of the COVID-19 ICU cases had absolute neutrophilia which showed that neutrophilia is an indicator of disease progression.[17] In the present study 393 cases showed absolute neutrophilia (95percentagecases). The absolute neutrophilia between categories was statistically significant (p value less than0.0001) with neutrophilia increasing from Category A to Category B to Category C. A study by Wu CM et al reported that, among the laboratory parameters of COVID-19 patients, 34.5percentage of patients with ARDS developed higher neutrophil count than those without ARDS and it was statistically significant (p value less than0.001).[18] Increase in neutrophil count is usually associated with activation of neutrophils which is required for immune response to fight against the virus. However high neutrophil count results in cytokine storm which leads to severe disease with clinical manifestation.[18] Other studies report that neutrophilia is due to cytokine storm. Coronavirus binds to ACE-2 receptors present on type-2 pneumocytes and releases cytokines especially IL-6 causing cytokine storm which subsequently induces and recruits more neutrophils which could be one of the causes for neutrophilia. Increase in number of neutrophils causes suppression and reduction in other WBCs as lymphocytes, eosinophils and monocytes.[19]
The present study showed lymphopenia (less than1.0×109/L) in 60.2percentage cases (247 cases). The ALC decreased from Category A to B to C with SARS and it was statistically significant (p value less than0.0001). Usually, lymphopenia occurs with leucopenia. Lymphopenia can occur even with normal WBC count. Zhongnan Hospital affiliated to Wuhan university reported lymphopenia in 138 patients (70.3percentage) with COVID-19.[20] A study by Wu C et al reported that in 50percentage cases of COVID 19 initial laboratory investigation showed lymphopenia (64percentage).[18] Lymphocytes are the crucial antiviral cells. The lymphocyte count is reported to continuously decline in severe COVID ICU patients in a study by Zhang et al. [20] A study done by Singh et al suggests that the cause of lymphopenia could be due to expression of ACE-2 receptors on lymphocytes in lungs and due to viral cytopathic effect resulting in lysis of lymphocytes and resulting in lymphopenia.[21] Among the cases which showed lymphopenia in present the study, most of the cases were in Category C indicating the disease progression.
In the present study eosinopenia was observed in all categories of COVID-19 cases and eosinophil count was statistically significant between the categories with p value less than0.001. In the present study 150 cases (36percentage) showed eosinopenia of which 130 cases (86percentage) were in Category C. A study by Yang M et al reported that eosinopenia was observed in severe COVID-19 cases and it improved on discharge of the patient. Thus, improvement of eosinopenia can serve as an indicator of improving clinical condition of the patient.[22]
In the present study basophil count was decreased in all categories of COVID -19 cases and was unrelated to severity of the disease. But study done by Sun Y et al showed lower basophil count in severe COVID-19 cases.[23]
In the present study monocytes were decreased in all categories of COVID-19 and was unrelated to the severity of COVID-19. But study by Sun S. et al showed monocytopenia in severe COVID-19 cases. The cause for monocytopenia can be due to increase in neutrophils following cytokine storm suppressing all other WBCs.[19]
A study by Tang N et al has reported thrombocytopenia in 12percentage COVID cases, thrombocytosis in 3.9
Haematology parameters can be considered to predict progression of the disease and assess prognosis in COVID-19 infection. Total WBC count, ANC, ALC, AEC, AMC, platelet count, NLR, MLR, ELR and PLR can be considered while monitoring COVID-19 cases. O positive blood group cases and cases with raised ESR are to be monitored more carefully.
Nil.
Nil.
Nil.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
